Group One Trading’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,995
Closed -$39.6K 8383
2026
Q1
$38.4K Buy
+1,995
New +$39.3K ﹤0.01% 5465
2025
Q3
Sell
-6,892
Closed -$129K 9063
2025
Q2
$127K Buy
6,892
+1,800
+35% +$31.9K ﹤0.01% 4752
2025
Q1
$89K Buy
5,092
+1,670
+49% +$28.2K ﹤0.01% 4681
2024
Q4
$59.3K Buy
3,422
+1,266
+59% +$23.1K ﹤0.01% 4926
2024
Q3
$40.1K Buy
+2,156
New +$36.3K ﹤0.01% 4792
2023
Q4
Sell
-585
Closed -$8.31K 8106
2023
Q3
$8.15K Buy
+585
New +$7.48K ﹤0.01% 6466
2022
Q1
Sell
-886
Closed -$12.1K 8620
2021
Q4
$12K Sell
886
-9,741
-92% -$138K ﹤0.01% 7282
2021
Q3
$156K Buy
+10,627
New +$180K ﹤0.01% 5434
2019
Q2
Sell
-3,036
Closed -$59K 5333
2019
Q1
$59K Buy
3,036
+3,000
+8,333% +$56.8K ﹤0.01% 3477
2018
Q4
$1K Sell
36
-300
-89% -$6.04K ﹤0.01% 4744
2018
Q3
$8K Buy
+336
New +$7.61K ﹤0.01% 4722
2016
Q4
Sell
-1,050
Closed -$24.1K 4790
2016
Q3
$26K Buy
+1,050
New +$25.2K ﹤0.01% 3688
2015
Q3
Sell
-200
Closed -$5K 5148
2015
Q2
$5K Buy
+200
New +$5.68K ﹤0.01% 4500

Other funds holding SBRA

Group One Trading's SBRA Position: Q2 2026 in Review

Group One Trading sold out of Sabra Healthcare REIT (SBRA) in Q2 2026, closing a stake of 1,995 shares — an estimated $39.6K sold.

Group One Trading first reported a position in SBRA in Q2 2015 and held it in 13 quarters. The position peaked at $156K in Q3 2021. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Group One Trading reported no remaining Sabra Healthcare REIT position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 1,995 Sabra Healthcare REIT shares in Q2 2026, an estimated $39.6K.
  • Group One Trading first reported a position in Sabra Healthcare REIT in Q2 2015 and held it in 13 quarters.
  • Group One Trading's Sabra Healthcare REIT position peaked at $156K in Q3 2021.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.